摘要
目的:研究薯蓣皂苷对人口腔鳞癌细胞SCC4、SCC25 DNA损伤和凋亡的影响及其可能的机制。方法:SCC4、SCC25细胞用不同浓度薯蓣皂苷(0.0、0.1、0.3、1.0、3.0、10.0和30.0μmol/L)处理48 h,通过CCK-8实验检测细胞活力;不同浓度(0.0、1.0、2.0、4.0μmol/L)薯蓣皂苷处理SCC4细胞48 h,采用免疫荧光技术检测γH2AX在SCC4细胞核内的表达情况;通过Western blotting检测DNA损伤修复蛋白的表达情况;采用流式细胞术检测细胞凋亡率,最后通过Western blotting检测细胞凋亡相关蛋白的表达变化。结果:薯蓣皂苷浓度依赖性地抑制了SCC4和SCC25细胞的活性(P<0.05);与薯蓣皂苷0.0μmol/L组比较,各薯蓣皂苷处理组SCC4细胞核中γH2AX的荧光表达强度显著上调(P<0.05);与薯蓣皂苷0.0μmol/L组比较,各薯蓣皂苷处理组SCC4、SCC25细胞DNA损伤信号蛋白P-ATM、P-CHK1、P-CHK2、γH2AX表达上升;与薯蓣皂苷0.0μmol/L组比较,各薯蓣皂苷处理组SCC4、SCC25细胞Cleaved-PARP、Cleaved-Caspase-3蛋白表达均升高。结论:薯蓣皂苷能抑制口腔鳞癌细胞的活性,并促进细胞的凋亡,其作用机制可能和其促进细胞的DNA损伤有关。
Objective:To investigate the effects of Dioscin on DNA damage and apoptosis in SCC4 and SCC25 human OSCC cells and explore potential underlying mechanisms.Methods:SCC4 and SCC25 cells were treated with various concentrations of Dioscin(0.0,0.1,0.3,1.0,3.0,10.0 and 30.0μmol/L)for 48 hours,and cell viability was assessed using the CCK-8 assay.Immunofluorescence was used to evaluateγH2AX expression in SCC4 cell nuclei after treatment with different Dioscin concentrations(0.0,1.0,2.0,4.0μmol/L)for 48 hours.The expression of DNA damage repair proteins was examined by Western blotting.Flow cytometry was employed to measure apoptosis rates,and changes in the expression of apoptosis-related proteins were detected using Western blotting.Results:Dioscin exhibited a concentration-dependent inhibition of SCC4 and SCC25 cell activity(P<0.05).It significantly increased the fluorescence intensity ofγH2AX in SCC4 cell nuclei compared to the untreated group(P<0.05)and activated the expression of DNA damage signal proteins,including P-ATM,P-CHK1,P-CHK2,andγH2AX.Dioscin also dose-dependently facilitated the activation of apoptosis-regulating proteins Cleaved-PARP and Cleaved-Caspase-3.Conclusion:Dioscin can suppress the activity of oral squamous cell carcinoma cells and promote apoptosis,and its mechanism may be linked to its induction of DNA damage in these cells.
作者
王小聪
章作号
李洋阳
张慧琳
黄子璇
乐曼妮
李明
WANG Xiaocong;ZHANG Zuohao;LI Yangyang;ZHANG Huilin;HUANG Zixuan;LE Manni;LI Ming(School of Stomatology,Hunan University of Chinese Medicine,Changsha Hunan 410208,China;Changsha Stomatological Hospital,Changsha Hunan 410004,China)
出处
《中医药导报》
2024年第7期20-24,共5页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金
湖南省自然科学基金面上基金项目(2022JJ30630)
湖南省教育厅重点项目(22A0249)。